Ninepoint Cannabis & Alternative Health Fund - Series F

Ninepoint Cannabis & Alternative Health Fund

Show Tour
NPP5421
Ninepoint Cannabis & Alternative Health Fund
  • Daily NAV Change · As at 12/5/2025
    -$0.15 (-1.59%)
  • NAV · As at 12/5/2025
    $9.29
  • Risk Tolerance
    High
  • Inception Date
    8/5/2017
Disclaimer

Overview

A more health-conscious consumer, an aging population, and legalization of cannabis have introduced new investment opportunities in the alternative health care sector.

Ninepoint Cannabis & Alternative Health Fund can help investors benefit from:

  • Increasing demand for alternative healthcare

    Increasing demand for alternative healthcare

    The use of nutraceuticals and cannabis to treat and prevent disease is expected to grow as new applications increase.

  • Access to an early stage sector

    Access to an early stage sector

    With the legalization of cannabis, the industry is anticipating high growth in medical and recreational use.

  • Aging demographics

    Aging demographics

    A rise in healthcare expenditures, driven by an aging global population, is pushing consumers to seek cheaper alternatives to treat chronic conditions.

  • Focus on reducing volatility

    Focus on reducing volatility

    Active management helps to reduce the risk of investing in the volatile cannabis sector by investing in liquid securities and allocating to other nutraceutical sectors.

Fund Objective

The investment objective of the fund is to achieve growth by investing primarily in equity securities of companies engaged in nutrition, nutraceuticals and new forms of medicines and pharmaceutical solutions (including cannabis). 

Investment Team

  • Ninepoint Partners Sub Advised by Faircourt Asset Management
    Ninepoint Partners Sub Advised by Faircourt Asset Management
    Faircourt Asset Management Inc. is an employee owned investment management company, widely recognized as an innovator in the Canadian fund industry. Faircourt was founded in 2002 and has established a reputation for innovative investment solutions. Faircourt created UIT Funds in 2016, offering unique investment themes for Canadian investors. The firm manages and advises closed end funds, mutual funds and institutional mandates with approximately $650 million in assets under administration.
    View Full Bio

Series F Performance

Compound Returns

As at 11/28/2025 (Series F) NPP5421
MTD % YTD % 1Y % 3Y % 5Y % 10Y % Inception %†
0.87
As at 12/5/2025 		-7.38 -12.31 -14.14 -14.64 - 0.23
†Inception Date: August 5, 2017

Monthly Returns (%)

As at 10/31/2025 (Series F) NPP5421
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total
2025 -2.13 -0.50 -8.77 1.88 -4.77 -1.46 2.13 17.33 -1.33 -3.76 -3.34
2024 14.82 -0.30 8.01 4.37 -16.31 -2.21 1.41 -8.73 6.38 -2.42 -12.29 -5.33 -15.74
2023 -3.56 -1.71 -3.70 1.63 -4.35 -0.46 -1.90 9.84 1.53 -9.08 7.50 0.52 -5.06
2022 -12.43 1.09 -0.47 -10.87 -4.12 -9.03 2.49 4.08 -8.99 9.42 1.50 -14.59 -36.93
2021 11.09 10.12 -3.96 -1.94 -2.85 1.63 -5.56 -4.23 -2.79 -7.58 2.68 0.07 -5.03
2020 0.38 -10.01 -5.74 8.13 9.63 -3.34 11.54 3.36 -6.02 6.51 21.08 2.10 39.21
2019 19.41 4.97 5.17 0.14 -6.82 -4.42 -4.16 -5.67 -8.19 -1.02 0.84 -3.17 -5.69
2018 4.16 -6.10 -1.91 0.33 9.00 4.38 -5.03 23.20 12.33 -9.38 -1.93 -8.10 17.55
2017 -2.27 5.13 11.66 11.92 15.88 48.78

Growth of $10,000 Invested

As at 10/31/2025 (Series F) NPP5421

Risk Tolerance

  • Low
  • Low - Med
  • Medium
  • Med - High
  • High

Portfolio

As at 10/31/2025

Sector Allocation

Sector Weight %
Cannabis 48.20
Other Wellness 26.20
Pharmaceuticals & Health Technoogy 18.66
Cash & Cash Equivalents 4.33
Organics, Supplements & Neutraceuticals 2.61

Geographic Allocation

Sector Weight %
United States 55.20
Canada 39.58

Top Ten Holdings

Issuer Name
Abbott Laboratories
Amazon.Com Inc
Costco Wholesale Corporation
Cronos Group Inc
Glass House Brands Inc
Green Thumb Industries Inc
Icanic Brands Co
Microsoft Corporation
Quest Diagnostics Incorporated
Trulieve Cannabis Corp

Statistical Analysis

As at 10/31/2025 (Series F) NPP5421
Statistics Fund
Cumulative Return 6.35%
Sharpe Ratio 0.09
Standard Deviation 27.08%
Total Positive Months 46
Total Down Months 52
Growth of 10K $10,635.12

Facts, Fees & Fund Codes

Facts
Fund Type
North American Equity Growth
Inception Date
Series A: 3/27/2017
Series F: 8/4/2017
Registered Tax Plan Status
Eligible
Distributions
-
Performance Fee
-
Minimum Initial Investment
$500
Minimum Subsequent Investment
$25
Minimum Investment Term
20 days (1.5% penalty)
Redemptions
Daily
Valuations
Daily
Fees
Management Fee
Series A: 2.25%
Series D: 1.25%
Series F: 1.25%
Fund Codes
Series A NPP5420
Series D NPP5422
Series F NPP5421

Documents

All returns and fund details are a) based on Series F shares; b) net of fees; c) annualized if period is greater than one year; d) as at 10/31/2025. Where applicable, all figures are annualized and based on monthly returns since inception. Risk-free rate and minimum acceptable rate calculated using rolling 90-day CDN T-bill rate. The rate of return or mathematical table shown is used only to illustrate the effects of the compound growth rate and is not intended to reflect future values of the mutual fund or returns on investment in the mutual fund. Top ten holdings and geographic allocation as at 10/31/2025. Top ten holdings based on % of net asset value. Geographic allocation based on % of net asset value and excludes cash. Numbers may not add up due to rounding. Cash and cash equivalents include non-portfolio assets and/or liabilities.

The rate of return is used only to illustrate the effects of the compound growth rate and is not intended to reflect future values of the investment fund or returns on investment in the investment fund.

The Fund is generally exposed to the following risks: Active management risk; Cannabis sector risk; Concentration risk; Currency risk; Cybersecurity risk; Derivatives risk; Exchange traded funds risk; Foreign investment risk; Inflation risk; Market risk; Regulatory risk; Securities lending, repurchase and reverse repurchase transactions risk; Series risk; Short selling risk; Specific issuer risk; Sub-adviser risk; Tax risk.

Ninepoint Partners LP is the investment manager to a number of funds (collectively, the “Funds”). Commissions, trailing commissions, management fees, performance fees (if any), and other expenses all may be associated with investing in the Funds. Please read the prospectus carefully before investing. The indicated rates of return for series F units of the Funds for the period ended 10/31/2025 are based on the historical annual compounded total returns including changes in unit value and reinvestment of all distributions or dividends and do not take into account sales, redemption, distribution or optional charges or income taxes payable by any securityholder that would have reduced returns. Mutual funds are not guaranteed, their values change frequently and past performance may not be repeated. This communication does not constitute an offer to sell or solicitation to purchase securities of the Funds.

The information contained herein does not constitute an offer or solicitation by anyone in the United States or in any other jurisdiction in which such an offer or solicitation is not authorized or to any person to whom it is unlawful to make such an offer or solicitation. Prospective investors who are not a resident in Canada should contact their financial advisor to determine whether securities of the Fund may be lawfully sold in their jurisdiction.

Ninepoint Partners LP: Toll Free: 1.866.299.9906. Dealer Services: CIBC Mellon GSSC Record Keeping Services: Toll Free: 1.877.358.0540